Study Helps Unravel Mysteries Of Brain's Endocannabinoid System - NIDA Research Could Lead To Better Treatment For Pain And Marijuana Addiction
Main Category: Pain / AnestheticsAlso Included In: Alcohol / Addiction / Illegal Drugs
Article Date: 17 Mar 2009 - 4:00 PDT
New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana. The results of this study,ledby researchers from Stony Brook University, were published March 16 in the Proceedings of the National Academy of Sciences.
Endocannabinoids are known to play a role in numerous physiological processes, including appetite, memory, and pain. Researchers had long suspected that endocannabinoids needed a specific transporter that would ferry them to the location where they are broken down. This study successfully identified a couple of previously known fatty acid binding proteins (FABPs) as capable of carrying the endocannabinoid anandamide (also known as AEA) from the cell membrane, through the cell interior, to the location where it is destroyed.
"This finding is important because it significantly expands the range of potential targets for developing medications that could help fight pain, addiction, and other disorders,"said NIDA Director Dr. Nora D. Volkow. "For example, the manipulation of the endocannabinoid system has the potential to provide sorely needed therapeutics for the management of severe pain that are devoid of the side effects of opiate analgesics."
The breakdown of AEA requires two factors. First, because AEA is a fatty compound and thus unable to move inside the watery cellular environment, there needs to be a mechanism for transporting AEA to the location where it is inactivated. Second, the cell must express an enzyme called FAAH, which is responsible for breaking down and inactivating AEA. In the laboratory, the researchers coaxed a nonneuronal cell type (COS-7) to express FAAH. These FAAH-expressing COS-7 cells were able to break down AEA efficiently, indicating that the intracellular AEA transport mechanism was already present and operational in these cells. The researchers identified these carriers as two different, previously known fatty-acid-binding proteins (FABPs). By specifically inhibiting FABPs, they were able to decrease the breakdown of AEA by about 50 percent.
"Inhibiting FABPs could potentially raise the levels of AEA in the brain's synapses," said Dr. Dale Deutsch, lead author of the study. "Naturally occurring AEA levels have been shown to curb pain without the negative side effects, such as motor coordination problems, of molecules like THC that can also bind the cannabinoid receptor. So it's advantageous to try and target AEA for therapeutic purpose."
"From a theoretical viewpoint, this approach could be used for treating marijuana addiction," said Dr. Volkow. "Compounds that inhibit FABPs could produce an effect similar to nicotine patches for smokers or methadone for opiate replacement. This line of research may also be important for other types of addiction, such as chronic alcohol abuse, which also affects AEA levels," she explained.
In addition to pain control, researchers are also examining manipulation of the endocannabinoid system for treating anxiety, obsessive-compulsive disorder, traumatic brain injury, and other substance abuse disorders.
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.
Source
National Institute on Drug Abuse
Visit our pain / anesthetics section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/142522.php>
APA
http://www.medicalnewstoday.com/releases/142522.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Marijuana addicting?
posted by c doyle on 27 Sep 2010 at 2:44 pmDr. Volkow, in the above article talked about treating Marijuana addiction. Since when is MARIJUANA addictive? In order for something to addicting you have to suffer from withdraw symptoms when you stop using. There is NO withdraw from pot. Cannabis is the worlds most useful and medicinal natural resource known to man. When will someone grow a set and finally tell the truth about the benefits of Cannabis?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





